The role of sympathetic nerve associated macrophages during pancreatic adenocarcinoma progression
交感神经相关巨噬细胞在胰腺腺癌进展中的作用
基本信息
- 批准号:10315610
- 负责人:
- 金额:$ 6.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAdoptive TransferAdrenergic AgentsAdrenergic ReceptorAntitumor ResponseAutonomic nervous systemBindingBiologyBone MarrowCancer ModelCell CommunicationCell ProliferationCell physiologyCell surfaceCellsCommunicationComplexDataDiseaseDoctor of PhilosophyEnzymesFailureGenesHistologicHumanImmuneImmune systemImmunosuppressionImmunotherapeutic agentImmunotherapyIn SituIncidenceIntervention StudiesInvadedInvestigationKPC modelKnock-outLabelMalignant NeoplasmsMatrix MetalloproteinasesMediatingMethaqualoneModelingMolecularMolecular TargetMusNeoplasm MetastasisNerveNerve FibersNeuroimmuneNeuronsNeurotransmittersNorepinephrinePancreasPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaParacrine CommunicationPatient-Focused OutcomesPatientsPhysiologicalPlayPopulationProcessProductionPrognostic FactorRoleSignal TransductionSiteSliceTissuesTumor Cell InvasionTumor-infiltrating immune cellsWorkadrenergic blockautonomic nervebasecellular targetingchemical releasechemokineclinical investigationcytokineglial cell-line derived neurotrophic factorhuman tissueimmune functionimmunogenicityimprovedin vivomacrophagemortalitymouse modelnano-stringneoplastic cellneurotransmitter releasenovel therapeutic interventionpancreatic cancer modelpancreatic neoplasmperineuralreconstructionrelating to nervous systemresponsetooltranscriptomicstumortumor microenvironmenttumor progressiontumor-immune system interactionstumorigenic
项目摘要
Project Summary/Abstract
Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality rate of all major cancers. While
immunotherapy has revolutionized treatment for numerous cancers, such treatments for patients with pancreatic
ductal adenocarcinoma (PDAC) have not been successful. Failure of the current immunotherapeutic approaches
are due to numerous features of pancreatic tumors including; poor immunogenicity and a highly
immunosuppressive tumor microenvironment (TME). Macrophages are considered as a focal point for
interventional studies during PDAC given that they regulate immunosuppression, promote a pro-fibrotic
microenvironment, as well as play an essential role in promoting tumor progression along local nerves. The
autonomic nervous system work in close partnership with local macrophages. Autonomic nerves stimulate
cytokine and chemokine production in macrophages that contribute to their aforementioned functions, however,
the signaling mechanisms by which nerves communicate with the immune system and coordinate the release of
tumorigenic factors are unknown. Based on our preliminary data, I hypothesize that noradrenaline (NA) released
from sympathetic nerves binds to adrenergic receptors on sympathetic nerve associated macrophages (SAMs),
which consequently support tumor progression. To study the communication between local pancreatic nerves
and immune cells, we are using ex vivo pancreatic tissue slices from human and mouse PDAC tumors. With this
technological platform, we are able to visualize nerves, macrophages, and tumor cells with minimal disruption
from their natural state. We will characterize [Ca2+]i responses in macrophages in response to autonomic
neurotransmitters, as well as use a targeted in-vivo approach in order to determine if blocking adrenergic
signaling within immune cells promotes anti-tumor responses. Combined with our preliminary physiological data,
we will use molecular approaches to further explore this crosstalk. We expect our results to identify
communication networks between macrophages, tumor cells and autonomic nerves in the setting of PDAC
perineural invasion that will prompt new therapeutic approaches for this deadly disease.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Robert Weitz其他文献
Jonathan Robert Weitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Robert Weitz', 18)}}的其他基金
The role of sympathetic nerve associated macrophages during pancreatic adenocarcinoma progression
交感神经相关巨噬细胞在胰腺腺癌进展中的作用
- 批准号:
10653062 - 财政年份:2021
- 资助金额:
$ 6.64万 - 项目类别:
The role of sympathetic nerve associated macrophages during pancreatic adenocarcinoma progression
交感神经相关巨噬细胞在胰腺腺癌进展中的作用
- 批准号:
10458523 - 财政年份:2021
- 资助金额:
$ 6.64万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 6.64万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 6.64万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 6.64万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 6.64万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 6.64万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 6.64万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 6.64万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 6.64万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 6.64万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 6.64万 - 项目类别:














{{item.name}}会员




